Clinical Trials Browser

OTHER × Liver Neoplasms × Gefitinib × Clear all

NCT00282100 2019-04-16

Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms